These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17401464)

  • 1. Antagonistic effects of sodium butyrate and N-(4-hydroxyphenyl)-retinamide on prostate cancer.
    Kuefer R; Genze F; Zugmaier W; Hautmann RE; Rinnab L; Gschwend JE; Angelmeier M; Estrada A; Buechele B
    Neoplasia; 2007 Mar; 9(3):246-53. PubMed ID: 17401464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cells.
    Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
    Mol Carcinog; 2002 Nov; 35(3):127-37. PubMed ID: 12410564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of c-jun for testosterone-induced sensitization to N-(4-hydroxyphenyl)retinamide-induced apoptosis.
    Shimada K; Nakamura M; Ishida E; Kishi M; Konishi N
    Mol Carcinog; 2003 Mar; 36(3):115-22. PubMed ID: 12619033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Jun N-terminal kinase mediates apoptotic signaling induced by N-(4-hydroxyphenyl)retinamide.
    Chen YR; Zhou G; Tan TH
    Mol Pharmacol; 1999 Dec; 56(6):1271-9. PubMed ID: 10570055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of N-(4-hydroxyphenyl)retinamide-induced autophagy at a lower dose enhances cell death in malignant glioma cells.
    Tiwari M; Bajpai VK; Sahasrabuddhe AA; Kumar A; Sinha RA; Behari S; Godbole MM
    Carcinogenesis; 2008 Mar; 29(3):600-9. PubMed ID: 18174255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent effect of 5-HPBR, a butanoate derivative of 4-HPR, on cell growth and apoptosis in cancer cells.
    Han HS; Kwon YJ; Park SH; Kim EJ; Rho YS; Sin HS; Um SJ
    Int J Cancer; 2004 Mar; 109(1):58-64. PubMed ID: 14735468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells.
    Roberson KM; Penland SN; Padilla GM; Selvan RS; Kim CS; Fine RL; Robertson CN
    Cell Growth Differ; 1997 Jan; 8(1):101-11. PubMed ID: 8993839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoid metabolism in the prostate: effects of administration of the synthetic retinoid N-(4-hydroxyphenyl)retinamide.
    Lewis KC; Hochadel JF
    Cancer Res; 1999 Dec; 59(23):5947-55. PubMed ID: 10606240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
    Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
    Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p-Dodecylaminophenol derived from the synthetic retinoid, fenretinide: antitumor efficacy in vitro and in vivo against human prostate cancer and mechanism of action.
    Takahashi N; Watanabe Y; Maitani Y; Yamauchi T; Higashiyama K; Ohba T
    Int J Cancer; 2008 Feb; 122(3):689-98. PubMed ID: 17955489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-(4-hydroxyphenyl)retinamide (4-HPR) decreases neoplastic properties of human prostate cells: an agent for prevention.
    Sharp RM; Bello-DeOcampo D; Quader ST; Webber MM
    Mutat Res; 2001 Sep; 496(1-2):163-70. PubMed ID: 11551492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell death induced by N-(4-hydroxyphenyl)retinamide in human epidermal keratinocytes is modulated by TGF-beta and diminishes during the progression of squamous cell carcinoma.
    Davies M; Paterson IC; Ganapathy A; Prime SS
    Int J Cancer; 2006 Dec; 119(12):2803-11. PubMed ID: 17044020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids.
    Bassani B; Bartolini D; Pagani A; Principi E; Zollo M; Noonan DM; Albini A; Bruno A
    PLoS One; 2016; 11(7):e0154111. PubMed ID: 27367907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
    Ohlmann CH; Jung C; Jaques G
    Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear retinoid receptors are involved in N-(4-hydroxyphenyl) retinamide (Fenretinide)-induced gene expression and growth inhibition in HL-60 acute myeloid leukemia cells.
    Ozpolat B; Tari AM; Mehta K; Lopez-Berestein G
    Leuk Lymphoma; 2004 May; 45(5):979-85. PubMed ID: 15291358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Water-soluble derivatives of 4-oxo-N-(4-hydroxyphenyl) retinamide: synthesis and biological activity.
    Musso L; Tiberio P; Appierto V; Cincinelli R; Cavadini E; Cleris L; Daidone MG; Dallavalle S
    Chem Biol Drug Des; 2016 Oct; 88(4):608-14. PubMed ID: 27135197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturase 1.
    Poliakov E; Samuel W; Duncan T; Gutierrez DB; Mata NL; Redmond TM
    PLoS One; 2017; 12(4):e0176487. PubMed ID: 28448568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
    Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP
    J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-(4-hydroxyphenyl)retinamide.
    Jinno H; Steiner MG; Mehta RG; Osborne MP; Telang NT
    Carcinogenesis; 1999 Feb; 20(2):229-36. PubMed ID: 10069458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synthetic retinoid N-(4-hydroxyphenyl) retinamide (4-HPR) exerts antiproliferative and apoptosis-inducing effects in the androgen-independent human prostatic JCA-1 cells.
    Hsieh TC; Ng C; Wu JM
    Biochem Mol Biol Int; 1995 Oct; 37(3):499-506. PubMed ID: 8595390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.